NCT00566943

Brief Summary

The purpose of this study is to verify the performance of PSD Veritas to provide staple line protection during surgical procedures for obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Mar 2006

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 29, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 4, 2007

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

May 28, 2012

Completed
Last Updated

May 19, 2017

Status Verified

July 1, 2011

Enrollment Period

2.8 years

First QC Date

November 29, 2007

Results QC Date

December 18, 2009

Last Update Submit

April 19, 2017

Conditions

Keywords

Staple Line Reinforcement, Buttress

Outcome Measures

Primary Outcomes (2)

  • Linear and Circular Arm: Number of Subjects With Major Gastric Related Adverse Events Comparison Between Control and PSD Veritas Groups.

    Adverse events as measured through hospital discharge and 30 days post-discharge in both the linear and circular arms of the study.

    Discharge/ 30 days Linear Discharge/30/90 days Circular

  • Linear and Circular Arm: Number of Participants With a Leak as Determined by a Comparison of Control Group to PSD Veritas Group.

    Leak as determined by a comparison of control group to PSD Veritas group in both linear and circular arms.

    Discharge/30 Linear Discharge/30/90 days Circular

Secondary Outcomes (2)

  • Linear Arm: Comparison of Use of Endoclips or Sutures Used for Bleeding in Control Group Versus PSD Veritas Group

    Discharge and 30 days

  • Number of Participants With Stricture Requiring Intervention Between Control Group and PSD Veritas Group. Bleeding Assessment of Control Group to PSD Veritas.

    Discharge, 30 and 90 days

Study Arms (2)

Control

ACTIVE COMPARATOR

Patients who have laparoscopic Roux-en-Y gastric by-pass surgery without staple line buttress material. No buttress material will be used on staple lines including stomach/pouch, anastomostic junctions, (gastrojejunostomy (GJ) gastric to intestine, or jejunojejunostomy (JJ) intestine to intestine). intestine or mesentery. Patients who have laparoscopic Roux-en-Y gastric by-pass surgery without buttress at the GJ anastomosis. Linear buttress at the stomach/pouch staple line is required.

Procedure: Roux-en-Y gastric by-pass surgery with no buttress

PSD Veritas

EXPERIMENTAL

Linear Peri-Strips Dry Veritas Group: Patients who have laparoscopic Roux-en-Y gastric by-pass surgery with PSD Veritas used as a staple line buttress at the stomach/pouch. In addition to buttress of the stomach/pouch, patients may have PSD Veritas linear buttress at any of the following staple lines: intestine, mesentery, or anastomosis junction (gastrojejunostomy (GJ) gastric to intestine, or jejunojejunostomy (JJ) intestine to intestine). Circular Peri-Strips Dry Veritas Group: Patients who have laparoscopic Roux-en-Y gastric by-pass surgery with PSD Veritas circular buttress used as a staple line buttress at the GJ anastomosis. Linear buttress at the stomach/pouch is required.

Device: PSD Veritas Collagen Matrix

Interventions

Roux-en-Y gastric by-pass surgery. Surgeon creates a small pouch from the stomach and then by-passes a large portion of the small intestine. The body cannot absorb as many calories or nutrients thus resulting in weight loss.

PSD Veritas

Patients who have laparoscopic Roux-en-Y gastric by-pass surgery without staple line buttress material. No buttress material will be used on staple line including stomach/pouch, anastomostic junctions, (gastrojejunostomy (GJ) gastric to intestine, or jejunojejunostomy (JJ) intestine to intestine intestine to mesentery.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient 18 years or older
  • Patient willing to comply with follow-up evaluations
  • Patient understands nature of procedure and provides informed consent
  • Female patient has stated that she is not pregnant and will not become pregnant during trial.

You may not qualify if:

  • Patient currently enrolled in another device/drug trial that competes for same patient population
  • Patient with short life expectancy (12 months) wherever the cause is not linked to obesity
  • BMI is equal or less than 40 and equal to or less than 65
  • Patient does not meet National Institute of Health (NIH) criteria for gastric by-pass surgery
  • Patient has had previous buttress or other material used in the staple lines that will affect the outcome of this trial.
  • Patient has known sensitivity to bovine material

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri-Columbia

Columbia, Missouri, 65212, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Lesa Hobright-Turner, Director Clinical Affairs
Organization
Synovis Surgical Innovations

Study Officials

  • Roger De La Torre, MD

    Division of General Surgery University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2007

First Posted

December 4, 2007

Study Start

March 1, 2006

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

May 19, 2017

Results First Posted

May 28, 2012

Record last verified: 2011-07

Locations